Advertisement

All-Cause Mortality in Patients With Unprotected Left Main Coronary Disease: Comparison Between Stenting and Coronary Artery Bypass Grafting

      The interventions aimed at patients with unprotected left main coronary disease are supported by a vast amount of data, the interpretation of which is increasingly difficult. For this purpose, studies using traditional meta-analysis
      • Jiang W.B.
      • Zhao W.
      • Huang H.
      • Li C.L.
      • Zhang J.H.
      • Wang Y.
      • Fu G.S.
      Meta-analysis of effectiveness of first-generation drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease.
      • Jang J.S.
      • Choi K.N.
      • Jin H.Y.
      • Seo J.S.
      • Yang T.H.
      • Kim D.K.
      • Kim D.S.
      • Urm S.H.
      • Chun J.H.
      • Kang S.J.
      • Park D.W.
      • Lee S.W.
      • Kim Y.H.
      • Lee C.W.
      • Park S.W.
      • Park S.J.
      Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.
      • Palmerini T.
      • Biondi-Zoccai G.
      • Reggiani L.B.
      • Sangiorgi D.
      • Alessi L.
      • De Servi S.
      • Branzi A.
      • Stone G.W.
      Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention.
      and/or metaregression analysis

      Messori A, Maratea D, Fadda V, Trippoli S. Outcomes in patients with unprotected left main coronary disease: comparison between drug-eluting stents and coronary artery bypass grafting. Am J Cardiol (in press).

      are helpful, because they effectively synthesize the available information.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jiang W.B.
        • Zhao W.
        • Huang H.
        • Li C.L.
        • Zhang J.H.
        • Wang Y.
        • Fu G.S.
        Meta-analysis of effectiveness of first-generation drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease.
        Am J Cardiol. 2012; 110: 1764-1772
        • Jang J.S.
        • Choi K.N.
        • Jin H.Y.
        • Seo J.S.
        • Yang T.H.
        • Kim D.K.
        • Kim D.S.
        • Urm S.H.
        • Chun J.H.
        • Kang S.J.
        • Park D.W.
        • Lee S.W.
        • Kim Y.H.
        • Lee C.W.
        • Park S.W.
        • Park S.J.
        Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.
        Am J Cardiol. 2012; 110: 1411-1418
        • Palmerini T.
        • Biondi-Zoccai G.
        • Reggiani L.B.
        • Sangiorgi D.
        • Alessi L.
        • De Servi S.
        • Branzi A.
        • Stone G.W.
        Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention.
        J Am Coll Cardiol. 2012; 60: 798-805
      1. Messori A, Maratea D, Fadda V, Trippoli S. Outcomes in patients with unprotected left main coronary disease: comparison between drug-eluting stents and coronary artery bypass grafting. Am J Cardiol (in press).

        • Messori A.
        • Maratea D.
        • Fadda V.
        • Trippoli S.
        Antipsychotic drugs for relapse prevention in schizophrenia.
        Lancet. 2012; 380: 1055-1056